SCHEMBL19742297

SCHEMBL19742297

Cc1c(C)n(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)cc3)cc2)c2ccccc12.Cc1c(C)n(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)cc3)cc2)c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ TSPO P30536 4/20 0.43
▸ PTGER4 P35408 1/20 0.39
▸ GAA P10253 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ NPY5R Q15761 1/20 0.36
▸ HPGD P15428 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 3/20 0.34
▸ PLA2G2A P14555 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17906203 1.00 KDM4E (0.44) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL21266396 0.95 KDM4E (0.42) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL17906206 0.94 KDM4E (0.43) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL17122266 0.91 L3MBTL1 (0.53) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL17122268 0.91 L3MBTL1 (0.53) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL17122276 0.91 L3MBTL1 (0.53) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL13968515 0.91 L3MBTL1 (0.53) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL13968873 0.91 L3MBTL1 (0.53) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL13968510 0.91 L3MBTL1 (0.53) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL17122271 0.91 L3MBTL1 (0.53) KDM4EATML3MBTL1TSPOPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9966537-B2 Compositions with 2,3-disubstituted indoles as charge transport materials, and display devices fabricated therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2018-05-08 — — US disclosed
US-20170373253-A1 Compositions with 2,3-Disubstituted Indoles as Charge Transport Materials, and Display Devices Fabricated Therefrom DOW GLOBAL TECHNOLOGIES LLC 2017-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170373253-A1 Compositions with 2,3-Disubstituted Indoles as Charge Transport Materials, and Display Devices Fabricated Therefrom IDO2, HTR3D, IDO1 KDM4E 3319/4885ATM 4371/4885L3MBTL1 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback